Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians

Annals of Hematology

Volumn 93, Issue 8, 2014, Pages 1313-1318

  Gouda, Heba Mahmoud ^a   Khorshied, Mervat Mamdooh ^a   El Sissy, Maha Hamdi ^a   Shaheen, Iman Abdel Mohsen ^a   Mohsen, Mohsen Mokhtar Abdel ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

B NHL; Egypt; MMP2 1306C T; MMP2 735C T

Indexed keywords

GELATINASE A;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ALLELES; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 84904741139     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2054-8     Document Type: Article

References (18)

1. Nogai H, Dörken B, Lenz G (2001) Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol 29:1-9
2. Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH (2011) Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma. Int J Cancer 000:000-000
3. Skibola CF, Curry JD, Neiters A (2007) A genetic susceptibility to lymphoma. Haematologica 92:960
4. Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113-185 (Pubitemid 46911962)
5. Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Cancer Biol 10:415-433
6. Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional geneticvariants in the human matrixmetalloproteinase-2 gene: role of Sp1 inallele-specific transcriptional regulation. J Biol Chem 276:7549-7558
7. Vasku A, Tschoplova S, Izakovicova Holla L, Semradova V, Vacha J (2002) Genotype association of C(735)T polymorphism inmatrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis. Dermatology 262:204-205
8. Zhou Y, Yu C, Miao X, Tan W, Liang W, Xiong P, Sun T, Lin D (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 genes. Carcinogenesis 25:399-404 (Pubitemid 38344407)
9. Shao JY, Cao Y, Niao XP et al (2001) A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China. Chin J Cancer 30:620-626
10. Peng B, Cao L, Ma X, Wang W, Wang D, Yu L (2010) Meta-analysis of association between matrix metalloproteinasess2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis. doi:10.1093/mutage/geg015
11. Qui W, Zhou G, Zhai Y et al (2008) No association of MMp-7, MMP-8, and MMP-21 polymorphisms in a Chinese population. Cancer Epidemiol Biomarkers Prev 17:2514-2518
12. Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55:368-376
13. Wróbel T, Mazur G, Dzietczenia J, Gwbura K, Kuliczkowski K, Bogunia-Kubik K (2013) VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. BioMed Research International Volume 2013, Article ID 159813, 6 pages http://dx.doi.org/10.1155/2013/159813
14. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839 (Pubitemid 36542523)
15. O-Charoenrat P, Khantapura P (2006) The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2genes in head and neck cancer. Oral Oncol 42:257-267
16. Negard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Ostenstad B, Sandset PM, Iversen PO (2009) Alteration in regulators of the extracellular matrix in non-Hodgkin lymphomas. Leuk Lymphoma 50:998-1004
17. Vasku A, Vasku J.B, Necas M., Vasku V (2010) Matrix Metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stage. Journal of Biomedicine and Biotechnology. 5
18. Mossböck G, Weger M, Faschinger C, Zimmermann C, Schmut O, Renner W, El-Shabrawi Y (2010) Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas. Mol Vis 16:1764-1770